Trasmab 440 mg Injection
  1. Home
  2. Pharma Products
  3. Bdr Pharmaceuticals Internationalas Pvt Ltd
  4. Trasmab 440 mg Injection

Trasmab 440 mg Injection

Trasmab 440 mg Injection contains trastuzumab, a targeted monoclonal antibody used to treat certain HER2-positive cancers. It is supplied as a 440 mg vial and is administered by intravenous infusion under medical supervision. It is mainly used in the treatment of HER2-positive breast cancer and certain stomach cancers.

BUY NOW

Category

Trastuzumab specifically targets the HER2 protein expressed on certain cancer cells and helps inhibit their growth. Trasmab may be used alone or with other anticancer medicines depending on the patient’s diagnosis and treatment protocol. The 440 mg presentation is supplied as a lyophilized formulation with a diluent for preparation before intravenous infusion. Treatment requires specialist supervision and appropriate monitoring, including assessment of cardiac function during therapy.

Technical Specification

Specification Details
Active Ingredient Trastuzumab
Strength 440 mg
Dosage Form Lyophilized Powder for Injection
Route of Administration Intravenous Infusion
Pack Size 1 Vial
Storage 2°C to 8°C

Product Also Known As

Trasmab 440 mg Injection, Trastuzumab 440 mg Injection, Trasmab Trastuzumab Injection, Trastuzumab Anticancer Injection, HER2 Targeted Therapy Injection, HER2 Positive Cancer Injection